Using Patient-Centered Guidelines in a Technology Platform to Improve Health Care in Adults With Sickle Cell Disease

NACompletedINTERVENTIONAL
Enrollment

67

Participants

Timeline

Start Date

July 1, 2018

Primary Completion Date

July 1, 2023

Study Completion Date

July 1, 2023

Conditions
Sickle Cell Disease
Interventions
OTHER

mobile health application

The user-driven technological tool will include an mHealth mobile phone application. Features of the application will be based on preliminary work from the investigators' sites. The mobile app will include fully searchable provider-facing and patient-facing interfaces with the SCD-specific guidelines. The provider-facing interface, designed to be used by providers, will be separated by patient's age to accommodate pediatric and adult providers. The patient-facing interface will display the guidelines that are age- and health literacy-appropriate. Through the mobile app, the investigators will reinforce important points of guideline content; motivate patient engagement through quizzes and text-message reminders; and facilitate peer support, for instance by forming teams to compete against each other to attain goals.

Trial Locations (2)

37203

Vanderbilt University, Nashville

43212

The Ohio State University Medical Center, Columbus

All Listed Sponsors
collaborator

Ohio State University

OTHER

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Vanderbilt University Medical Center

OTHER

NCT03629678 - Using Patient-Centered Guidelines in a Technology Platform to Improve Health Care in Adults With Sickle Cell Disease | Biotech Hunter | Biotech Hunter